• Return to Headlines

Recent 52-Week Low Surpassed in Shares of Pacific Biosciences of California (PACB)

By James Quinn

Pacific Biosciences of California (NASDAQ:PACB) traded at a new 52-week low today of $3.12. This new low was reached on below average trading volume as 817,000 shares traded hands, while the average 30-day volume is approximately 1.6 million shares.

Pacific Biosciences of California share prices have moved between a 52-week high of $14.00 and the current low of $3.12 and are currently at $3.20 per share. Over the past week, the 200-day moving average (MA) has gone up 0.9% while the 50-day MA has advanced 0.3%.

Pacific Biosciences of California (NASDAQ:PACB) has potential upside of 131.8% based on a current price of $3.20 and analysts' consensus price target of $7.42. The stock should find initial resistance at its 200-day moving average (MA) of $8.22 and further resistance at its 50-day MA of $8.85.

Pacific Biosciences of California Inc. has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. The Company's system enables real-time analysis of biomolecules with single molecule resolution.

SmarTrend recommended that its subscribers protect gains by selling shares of Pacific Biosciences of California on May 24th, 2017 by issuing a Downtrend alert when the shares were trading at $3.74. Since that call, shares of Pacific Biosciences of California have fallen 10.6%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows pacific biosciences of california

Ticker(s): PACB